M62.84 classifies sarcopenia — the progressive, age-related decline in skeletal muscle mass and strength that leads to reduced physical function, increased fall risk, and loss of independence.

Documentation tips

What should appear in the chart to support M62.84.

Source · Editorial brief grounded in 6 cited references ↓

• Record the specific muscle mass measurement method (DXA or BIA) and the result — payers expect objective evidence, not clinical impression alone.
• Document grip strength in kilograms with the instrument used; EWGSOP2 thresholds (<27 kg men, <16 kg women) are the standard clinical reference.
• Include gait speed or chair stand test results (SARC-F score ≥4 or gait speed ≤0.8 m/s) to satisfy functional performance documentation requirements.
• If an underlying condition drives the muscle loss, name it explicitly in the note so sequencing (underlying condition first, M62.84 second) is clear and defensible.
• Note functional impact — fall history, ADL limitations, mobility restrictions — to justify medical necessity and support DRG weight in inpatient settings.

Related CPT procedures

Procedure codes commonly billed with M62.84. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M62.84 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Using M62.50 (muscle wasting and atrophy, unspecified site) instead of M62.84 when the provider documents sarcopenia — these are distinct codes and the swap causes incorrect DRG assignment.
• Listing M62.84 as the first-listed diagnosis when a codeable underlying condition is present; the Tabular List requires the underlying etiology to be sequenced first.
• Conflating sarcopenia with cachexia (R64) — cachexia is driven by systemic disease wasting and has its own code; using M62.84 for a cachectic patient is inaccurate and audit-prone.
• Assigning M62.84 without objective muscle mass or strength measurements in the documentation — a clinical label without quantitative support is insufficient for audit defense.
• Omitting M62.84 entirely on surgical encounters where sarcopenia is a documented comorbidity affecting operative risk; missing it understates case complexity and may reduce appropriate reimbursement.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

Inclusion & exclusion notes

Per the official ICD-10-CM Tabular List.

Source · CDC ICD-10-CM Official Tabular List · 2026

Sibling codes

Other billable codes under M62.8 (laterality / anatomic variants).